207
Participants
Start Date
October 31, 2016
Primary Completion Date
December 31, 2021
Study Completion Date
December 31, 2022
Consolidation with chemotherapy (CT) or autologous hematopoietic stem cell transplantation (auto-HSCT)
"For CT, patients were treated with high dose cytarabine (HDAC), cytarabine at a dosage of 1-3 g/m2 q12 h ×6 doses, for 4-6 cycles.~For auto-HSCT, patients were treated with 3 cycles of HDAC and then bridged to auto-HSCT."
Consolidation with auto-HSCT or HLA-matched HSCT
"For auto-HSCT, patients were treated with 3 cycles of HDAC and then bridged to auto-HSCT.~For HLA-matched HSCT, patients were treated with 1-2 cycles of HDAC and then bridged to HLA-matched HSCT. HLA-matched donors were available in these patients."
allogeneic HSCT
For allogeneic HSCT, patients were treated with 1-2 cycles of HDAC and then bridged to allogeneic HSCT, including HLA-matched and haploidentical transplantation.
Zhujiang Hospital
OTHER
Nanfang Hospital, Southern Medical University
OTHER